Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly

Eur Respir J. 2019 Mar 18;53(3):1802396. doi: 10.1183/13993003.02396-2018. Print 2019 Mar.

Pei-Chun Chan^{1

2

3}, Pin-Hui Lee⁴, Min-Ju Lu⁴, You-Chieh Huang⁴, Teng-Yi Feng⁴, Wen-Wen Chen⁵, Chia-Chi Lee⁴, Yen-Fang Huang⁴, Chen-Yuan Chiang^{6

7

8}

¹ Division of Chronic Infectious Disease, Centers for Disease Control, Taipei, Taiwan pcanita.tw@cdc.gov.tw.
² Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
³ Dept of Pediatrics, National Taiwan University Hospital, National Taiwan University, College of Medicine, Taipei, Taiwan.
⁴ Division of Chronic Infectious Disease, Centers for Disease Control, Taipei, Taiwan.
⁵ Taiwan Drug Relief Foundation, Taipei, Taiwan.
⁶ Division of Pulmonary Medicine, Dept of Internal Medicine, Wanfang Hospital, Taipei Medical University, Taipei, Taiwan.
⁷ Division of Pulmonary Medicine, Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁸ International Union against Tuberculosis and Lung Disease, Paris, France.

No abstract available

Publication types